---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014323"
form_type: "8-K"
ticker: null
cik: "0000764195"
company_name: "VBI Vaccines Inc/BC"
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-04T00:13:39.452078+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# VBI Vaccines raises $2M in registered direct offering; discloses $23.7M cash as of Dec 31, 2023

## Summary
- Sold 2,272,728 common shares at $0.88 each with warrants to buy same at $0.76, 5-year term.
- Net proceeds ~$1.7M after placement agent fees; funds for working capital and general corporate purposes.
- Preliminary unaudited cash balance as of Dec 31, 2023: approximately $23.7M.
- Offering closed April 11, 2024; H.C. Wainwright acted as exclusive placement agent.
- Placement agent received warrants for 136,364 shares at $1.10 per share.

## SEC filing metadata
- accession: 0001493152-24-014323
- form_type: 8-K
- cik: 0000764195
- company_name: VBI Vaccines Inc/BC
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/0001493152-24-014323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014323
- JSON: https://secwatch.observer/filing/0001493152-24-014323.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014323.txt

## Key facts
- Material Agreements
  VBI Vaccines Inc/BC entered into Securities Purchase Agreement with institutional investors valued at $0.88 per Share (effective 2024-04-09).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investors
  - Value: $0.88 per Share
  - Effective: 2024-04-09
  source text: VBI Vaccines Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with institutional investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”), (i) 2,272,728 common shares (the “Shares”) of the Company, no par value per share (the “Common Shares”), and (ii) warrants (the “Common Warrants”) to purchase up to 2,272,728 Common Shares, at a purchase price of $0.88 per Share and associated Common Warrant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/0001493152-24-014323-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.